Mayo Clinic Labs
  • MayoACCESS
  • MayoLINK
  • Register
  • My Dashboard
  • Algorithms
  • Download Test Catalog & Interpretive Handbook
  • New Tests
  • NY State Informed Consent Tests
  • Performing Locations
  • Referred Tests
  • Specialty Testing
  • Test Updates
  • Critical Values & Results
  • Custom Gene Ordering
  • Forms
  • LIS Resources
  • MayoACCESS Resources
  • MayoLINK Resources
  • Order Your First Test
  • Patient Information and Signature Forms
  • Request Additional Testing
  • Send Additional Specimen
  • Collection & Preparation
  • Dangerous Goods Training
  • Shipping & Courier Guides
  • Shipping Regulations
  • Supplies
  • Billing
  • Contact Us
  • FAQ
  • IT Updates
  • Operational Updates
  • Quality & Compliance
  • Educational Resources
  • News
  • Outreach
  • Podcasts
  • Stories
  • Contact
  • Log Out
Insights
  • Education
  • News
  • Podcasting
  • Stories
A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.

July 21, 2025
Keynote speakers set for 2025 Classical Hematology Conference
August 6, 2025

At this year's Classical Hematology Conference we will be joined by Hematology experts, Adam Cuker, M.D. and Stephan Moll, M.D. Reserve your spot today.

Dr. Bill Morice offers data-driven reasons to retain lab services
August 5, 2025

William Morice II, M.D., Ph.D., highlights data-driven reasons health systems benefit from the lab service line and strategies to bolster performance.

Transformative Feedback: How to Overcome the Summer Slump
August 4, 2025

Review the art of delivering clear, constructive feedback; tips for navigating potentially challenging conversations with respect; highlighting the importance of positive feedback.

Bobbi Pritt, M.D., discusses new Lyme disease vaccine
August 24, 2022

Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic, was featured in a Health article regarding a new vaccine to prevent Lyme disease. The vaccine is in its final clinical trial phase and could be available in several years.

Mayo Clinic Laboratory and pathology research roundup: August 23
August 23, 2022

This week's research roundup features: High-sensitivity cardiac troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of acute chest pain

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
August 23, 2022

Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide treatment decisions. Often misdiagnosed, CIDP is treatable if detected early.

Bobbi Pritt, M.D., appears on Sirius XM for vector-borne disease talk
August 22, 2022

Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic and director of the Clinical Parasitology Laboratory, joined the Dr. Radio Internal Medicine show on Sirius XM to discuss vector-borne disease, detecting Lyme disease, and diagnosing monkeypox.

PD-L1 Testing by Immunohistochemistry
August 22, 2022

In this month's "Hot Topic," Anja Roden, M.D., discusses the role of PD-L1 interaction in the immune system, challenges of PD-L1 testing, and current PD-L1 companion testing in various tumor types.

Week in Review: August 19
August 19, 2022

Topic highlights include: Mayo Clinic Minute: prescribing nature for mental, physical health (video), Over-the-counter hearing aids expected this fall in US, UK becomes first country to approve updated Moderna vaccine targeting omicron

Patient-Scientists: A Valuable Perspective in Medical Research
August 19, 2022

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Delaney Liskey, a regenerative sciences Ph.D. student at the Mayo Clinic Graduate School of Biomedical Sciences, to discuss why patient-scientists are a valuable perspective in medical research, and what role they play.

Labor Day Specimen Shipment Alert
August 18, 2022

Due to the Labor Day holiday (recognized on Monday, September 5th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Ongoing evolution of monkeypox: Dr. Bill Morice
August 18, 2022

This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss how monkeypox can be transmitted, the possibilities of a future Emergency Use Authorization (EUA), and access to testing.

Reducing Canceled Labs Related to Specimen Integrity in the Neonatal Intensive Care Unit: A Quality Improvement Initiative
August 17, 2022

This “phlebotomy webinar” will walk learners through the quality improvement methodology and describe PDSA cycle interventions that were implemented in this unit which successfully reduced the amount of canceled labs due to specimen integrity.

Mayo Clinic Labs @Work: Tim Plummer
August 17, 2022

Tim Plummer is an operations administrator at Mayo Clinic Laboratories supporting the Division of Anatomic Pathology. He supports his team members by providing them with tools and resources to innovate and succeed. He has worked at Mayo Clinic for over 36 years and is driven by the determination to help people solve problems, help others be happy and successful, and be a part of solutions.

Membranous nephropathy assay: PMND1
August 16, 2022

John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a condition that can lead to kidney failure.

View MoreView Less
Mayo Clinic Labs
Mayo Clinic Labs
  • Mayo Clinic
  • About us
  • BioPharma
  • Cardiovascular services
  • Newsroom
Resources
  • FAQ
  • Policies
  • Quality
  • Careers
  • Insights
  • Terms of use
  • Privacy statement
Accounts
  • Mayo account
  • MayoLINK
  • Register
  • Dashboard
  • Log out
Contacts
  • Contacts
  • Customer service
Facebook Twitter Instagram LinkedIn YouTube
© 1995–2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.